Metformin may help to slow heart disease development in patients with type 1 diabetes by improving the levels of circulating endothelial progenitor cells (cEPCs), pro-angiogenic cells (PACs), colony forming units (CFU-Hill’s colonies), circulating endothelial cells (cECs), and PACs adhesion while maintaining glycemic control, according to new research.
Friday 26 August 2016
Metformin may help to slow heart disease development in patients with type 1 diabetes by improving the levels of circulating endothelial progenitor cells (cEPCs), pro-angiogenic cells (PACs), colony forming units (CFU-Hill’s colonies), circulating endothelial cells (cECs), and PACs adhesion while maintaining glycemic control, according to new research.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment